AI Summary
Jennifer Doudna, co-inventor of the Crispr gene-editing technology, expresses skepticism about artificial intelligence's potential to replace human contributions in scientific discovery. Her comments contribute to ongoing discussions regarding AI's influence on medical research and innovation.
- Jennifer Doudna is a professor of biochemistry at the University of California Berkeley and co-inventor of Crispr-Cas9 gene editing technology.
- Doudna received the Nobel Prize in Chemistry in 2020 for her work on Crispr.
- In a recent interview, she questioned the notion that AI, specifically OpenAI's ChatGPT, could take credit for drug discovery.
- Her skepticism reflects a broader debate about the role of AI in advancing medical research and innovation.
ai skepticismmedical innovationscientific discoverycrisprbiotechnology